SOMATIC MUTATIONS AT THE SRD5A2 LOCUS ENCODING PROSTATIC STEROID 5 alpha-REDUCTASE DURING PROSTATE CANCER PROGRESSION
- 1 April 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (4) , 1355-1358
- https://doi.org/10.1016/s0022-5347(01)61683-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- High frequency of genetic instability of microsatellites in human prostatic adenocarcinomaInternational Journal of Cancer, 1997
- Microsatellite Instability and Other Molecular Abnormalities in Human Prostate CancerJapanese Journal of Cancer Research, 1995
- Expression and Regulation of Steroid 5α-Reductase 2 in Prostate DiseaseJournal of Urology, 1994
- Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancerUrology, 1994
- Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)Human Molecular Genetics, 1993
- Molecular genetics of steroid 5 alpha-reductase 2 deficiency.Journal of Clinical Investigation, 1992
- Chromosomal abnormalities and related events in prostate cancerHuman Pathology, 1992
- The TNM classification of prostate cancerThe Prostate, 1992
- 5α‐REDUCTASE ACTIVITY IN HUMAN PROSTATE CANCER IS RELATED TO THE HISTOLOGICAL DIFFERENTIATION OF THE TUMOURClinical Endocrinology, 1985